Evidence map›Paper›PMID 20603330›Full record

ArticleThe Journal of cell biology2010

The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.

Zhihe Kuang, Rowena S Lewis, Joan M Curtis, Yifan Zhan, Bernadette M Saunders, Jeffrey J Babon, Tatiana B Kolesnik, Andrew Low, Seth L Masters, Tracy A Willson and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of cell biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 100 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Autophagy activation by the Becn1Brain, behavior, and immunity · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. On the human health benefits of microalgal phytohormones: An explorativeComputational and structural biotechnology journal · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Zhihe KuangThe Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Victoria, Australia.
Rowena S Lewis
Joan M Curtis
Yifan Zhan
Bernadette M Saunders
Jeffrey J Babon
Tatiana B Kolesnik
Andrew Low
Seth L Masters
Tracy A Willson
Lukasz Kedzierski
Shenggen Yao
Emanuela Handman
Raymond S Norton
Sandra E Nicholson
Walter and Eliza Hall Institute of Medical Research · AUCentenary Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inducible nitric oxide (NO) synthase (iNOS; NOS2) produces NO and related reactive nitrogen species, which are critical effectors of the innate host response and are required for the intracellular killing of pathogens such as Mycobacterium tuberculosis and Leishmania major. We have identified SPRY domain-containing SOCS (suppressor of cytokine signaling) box protein 2 (SPSB2) as a novel negative regulator that recruits an E3 ubiquitin ligase complex to polyubiquitinate iNOS, resulting in its proteasomal degradation. SPSB2 interacts with the N-terminal region of iNOS via a binding interface on SPSB2 that has been mapped by nuclear magnetic resonance spectroscopy and mutational analyses. SPSB2-deficient macrophages showed prolonged iNOS expression, resulting in a corresponding increase in NO production and enhanced killing of L. major parasites. These results lay the foundation for the development of small molecule inhibitors that could disrupt the SPSB-iNOS interaction and thus prolong the intracellular lifetime of iNOS, which may be beneficial in chronic and persistent infections.

Indexed as

Leishmania majorAnimalsCell LineDNA-Binding ProteinsGene Expression Regulation, EnzymologicLeishmaniasis, CutaneousMacrophagesMiceMice, KnockoutMycobacterium tuberculosisNitric Oxide Synthase Type IIProteasome Endopeptidase ComplexProtein Structure, TertiarySuppressor of Cytokine Signaling ProteinsUbiquitinationUbiquitin-Protein LigasesDNA-Binding ProteinsNitric Oxide Synthase Type IINos2 protein, mouseProteasome Endopeptidase ComplexSSB-2 protein, mouseSuppressor of Cytokine Signaling ProteinsUbiquitin-Protein Ligases

Identifiers

PMID20603330
PMCPMC2911665
OpenAlexW2129196952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.